We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Currency be a Drag on Nu Skin's (NUS) Q4 Earnings?
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) is slated to release fourth-quarter and 2018 results on Feb 13, after market close. This Utah-based personal care products company has a mixed earnings surprise history for the trailing four quarters. Let’s see how things are shaping up prior to the upcoming quarterly announcement.
Customers & Sales Leaders to Boost Performance
Nu Skin sells and distributes products through a network of sales leaders as well as customers that are spread across 50 global markets. Notably, the top line is consistently benefitting from growth in sales leaders. Additionally, the company is focusing to empower sales leaders through improved compensation, training and technological enhancements. In this regard, it is expanding the sales compensation program, Velocity, in different countries.
Moving on, Nu Skin boasts an expanding customer base that boosts growth in sales leaders as well. The company primarily relies on social media as well as well-knit product and marketing programs to expand its reach. Incidentally, customers grew approximately 9%, 8% and 7% in the trailing three quarters, respectively. Such upsides combined with effective product launches are likely to aid Nu Skin’s performance in the impending quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin’s gross margin has been unimpressive for a while. Gross margin slid approximately 190 basis points (bps), 180 bps and 140 bps during the third, the second and the first quarters of 2018, respectively. Such persistent declines in gross margin levels are considerable threats for the company’s overall profitability.
Also, unfavorable impacts from currency rates are a roadblock for the company. We note that a major share of Nu Skin’s revenues is sourced from international markets, thereby exposing the company to significant currency risks. In fact, the bottom line in the third quarter was hurt by foreign currency translation losses of almost 7 cents. Management earlier projected currency translations to drag earnings in 2018 by approximately 20 cents, which is a concern for the to-be-reported quarter as well. In fact, management expects fourth-quarter earnings per share in the range of $1.00-$1.07, including charges of 4 cents stemming from purchase accounting. This estimate reflects a considerable decline from earnings of $1.20 delivered the year-ago quarter.
Further, management anticipates revenues in the range of $665-$685 million, compared with year-ago quarter’s tally of $666 million. All said, let’s take a look at the Zacks Consensus Estimate for the upcoming quarter as well as the Zacks Model.
Estimates for the Quarter
The Zacks Consensus Estimate for fourth-quarter 2018 earnings is currently pegged at $1.03 per share, reflecting a decline of 14.2% from the year-ago quarter’s tally.
Further, the Zacks Consensus Estimate for the impending quarter’s revenues is currently pegged at $673.3 million, depicting moderate growth of 1% from the year-ago quarter’s reported figure.
Zacks Model
Our proven model does not show that Nu Skin will beat earnings estimates this quarter. A stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You can see the complete list of today’s Zacks #1 Rank stocks here.
Although Nu Skin carries a Zacks Rank #3, its Earnings ESP of 0.00% makes us less confident about an earnings surprise. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks Poised to Beat Earnings Estimates
Here are some companies you may want to consider as our model shows that they have the right combination of elements to beat earnings.
Turning Point Brands, Inc (TPB - Free Report) has Earnings ESP of +11.11% and a Zacks Rank #2.
Nomad Foods Limited (NOMD - Free Report) has an Earnings ESP of +1.45% and a Zacks Rank #2.
Ollie's Bargain Outlet Holdings, Inc (OLLI - Free Report) has an Earnings ESP of +0.21% and a Zacks Rank #2.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.
Image: Bigstock
Will Currency be a Drag on Nu Skin's (NUS) Q4 Earnings?
Nu Skin Enterprises, Inc. (NUS - Free Report) is slated to release fourth-quarter and 2018 results on Feb 13, after market close. This Utah-based personal care products company has a mixed earnings surprise history for the trailing four quarters. Let’s see how things are shaping up prior to the upcoming quarterly announcement.
Customers & Sales Leaders to Boost Performance
Nu Skin sells and distributes products through a network of sales leaders as well as customers that are spread across 50 global markets. Notably, the top line is consistently benefitting from growth in sales leaders. Additionally, the company is focusing to empower sales leaders through improved compensation, training and technological enhancements. In this regard, it is expanding the sales compensation program, Velocity, in different countries.
Moving on, Nu Skin boasts an expanding customer base that boosts growth in sales leaders as well. The company primarily relies on social media as well as well-knit product and marketing programs to expand its reach. Incidentally, customers grew approximately 9%, 8% and 7% in the trailing three quarters, respectively. Such upsides combined with effective product launches are likely to aid Nu Skin’s performance in the impending quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise | Nu Skin Enterprises, Inc. Quote
Gross Margin & Currency Woes
Nu Skin’s gross margin has been unimpressive for a while. Gross margin slid approximately 190 basis points (bps), 180 bps and 140 bps during the third, the second and the first quarters of 2018, respectively. Such persistent declines in gross margin levels are considerable threats for the company’s overall profitability.
Also, unfavorable impacts from currency rates are a roadblock for the company. We note that a major share of Nu Skin’s revenues is sourced from international markets, thereby exposing the company to significant currency risks. In fact, the bottom line in the third quarter was hurt by foreign currency translation losses of almost 7 cents. Management earlier projected currency translations to drag earnings in 2018 by approximately 20 cents, which is a concern for the to-be-reported quarter as well. In fact, management expects fourth-quarter earnings per share in the range of $1.00-$1.07, including charges of 4 cents stemming from purchase accounting. This estimate reflects a considerable decline from earnings of $1.20 delivered the year-ago quarter.
Further, management anticipates revenues in the range of $665-$685 million, compared with year-ago quarter’s tally of $666 million. All said, let’s take a look at the Zacks Consensus Estimate for the upcoming quarter as well as the Zacks Model.
Estimates for the Quarter
The Zacks Consensus Estimate for fourth-quarter 2018 earnings is currently pegged at $1.03 per share, reflecting a decline of 14.2% from the year-ago quarter’s tally.
Further, the Zacks Consensus Estimate for the impending quarter’s revenues is currently pegged at $673.3 million, depicting moderate growth of 1% from the year-ago quarter’s reported figure.
Zacks Model
Our proven model does not show that Nu Skin will beat earnings estimates this quarter. A stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You can see the complete list of today’s Zacks #1 Rank stocks here.
Although Nu Skin carries a Zacks Rank #3, its Earnings ESP of 0.00% makes us less confident about an earnings surprise. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks Poised to Beat Earnings Estimates
Here are some companies you may want to consider as our model shows that they have the right combination of elements to beat earnings.
Turning Point Brands, Inc (TPB - Free Report) has Earnings ESP of +11.11% and a Zacks Rank #2.
Nomad Foods Limited (NOMD - Free Report) has an Earnings ESP of +1.45% and a Zacks Rank #2.
Ollie's Bargain Outlet Holdings, Inc (OLLI - Free Report) has an Earnings ESP of +0.21% and a Zacks Rank #2.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.
Click to get it free >>